Interaction between Muscle and Bone.
10.11005/jbm.2014.21.1.29
- Author:
Hiroshi KAJI
1
Author Information
1. Department of Physiology and Regenerative Medicine, Kinki University Faculty of Medicine, Osaka, Japan. hkaji@med.kindai.ac.jp
- Publication Type:Review
- Keywords:
Bone and bones;
Muscles;
Osteoporosis;
Sarcopenia
- MeSH:
Axis, Cervical Vertebra;
Biomarkers;
Bone and Bones;
Fibrinogen;
Muscles*;
Osteoblasts;
Osteoporosis;
Physiology;
Sarcopenia;
Testosterone;
Vitamin D
- From:Journal of Bone Metabolism
2014;21(1):29-40
- CountryRepublic of Korea
- Language:English
-
Abstract:
The clinical significance of sarcopenia and osteoporosis has increased with the increase in the population of older people. Sarcopenia is defined by decreased muscle mass and impaired muscle function, which is related to osteoporosis independently and dependently. Numerous lines of clinical evidence suggest that lean body mass is positively related to bone mass, which leads to reduced fracture risk. Genetic, endocrine and mechanical factors affect both muscle and bone simultaneously. Vitamin D, the growth hormone/insulin-like growth factor I axis and testosterone are physiologically and pathologically important as endocrine factors. These findings suggest the presence of interactions between muscle and bone, which might be very important for understanding the physiology and pathophysiology of sarcopenia and osteoporosis. Muscle/bone relationships include two factors: local control of muscle to bone and systemic humoral interactions between muscle and bone. As a putative local inducer of muscle ossification, we found Tmem119, a parathyroid hormone-responsive osteoblast differentiation factor. Moreover, osteoglycin might be one of the muscle-derived humoral bone anabolic factors. This issue may be important for the development of novel drugs and biomarkers for osteoporosis and sarcopenia. Further research will be necessary to clarify the details of the linkage of muscle and bone.
